(TEVA) Teva Pharma Industries - Performance 1.7% in 12m
TEVA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
20.09%
#49 in Peer-Group
Rel. Strength
39.76%
#4637 in Stock-Universe
Total Return 12m
1.65%
#81 in Peer-Group
Total Return 5y
41.41%
#39 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 6.56 |
| High / Low | USD |
|---|---|
| 52 Week High | 22.77 USD |
| 52 Week Low | 12.82 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 26.03 |
| Buy/Sell Signal +-5 | -1.12 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: TEVA (1.7%) vs XLV (-4.8%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-3.42% | 131% | 313% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
3.1% | 16.7% | 81% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
0.51% | -14.7% | 405% | 63.7 | 35.8 | 1.2 | 58.2% | 18.9% |
| NOVN SW Novartis |
0.14% | 4.1% | 53.5% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-5.82% | 3.79% | 51.6% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-8.26% | -8.24% | 110% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-4.1% | -7.38% | 46.1% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| UCB BR UCB |
5.98% | 19.9% | 66.1% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: TEVA vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for TEVA
| Total Return (including Dividends) | TEVA | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -7.97% | 1.09% | 3.75% |
| 3 Months | 22.37% | 1.98% | 25.32% |
| 12 Months | 1.65% | -4.84% | 13.11% |
| 5 Years | 41.41% | 45.05% | 109.78% |
| Trend Score (consistency of price movement) | TEVA | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -74.6% | 20.4% | 80.3% |
| 3 Months | 60.7% | -22.1% | 97.2% |
| 12 Months | -36.1% | -76.5% | 45.4% |
| 5 Years | 50.7% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th19.50 | -8.96% | -11.30% |
| 3 Month | %th54.50 | 19.99% | -2.35% |
| 12 Month | %th59.50 | 6.82% | -10.13% |
| 5 Years | %th78.50 | -2.51% | -32.59% |
FAQs
Does Teva Pharma Industries (TEVA) outperform the market?
Yes,
over the last 12 months TEVA made 1.65%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.84%.
Over the last 3 months TEVA made 22.37%, while XLV made 1.98%.
Performance Comparison TEVA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
TEVA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.5% | -11.7% | -28.5% | -11% |
| US NASDAQ 100 | QQQ | -1% | -12.2% | -30.1% | -10% |
| German DAX 40 | DAX | -2.3% | -8.2% | -41.3% | -29% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.6% | -11.7% | -32.2% | -20% |
| Hongkong Hang Seng | HSI | -0.1% | -11% | -49% | -37% |
| India NIFTY 50 | INDA | 0.2% | -8.8% | -29% | 3% |
| Brasil Bovespa | EWZ | 0.2% | -13.9% | -50.5% | -6% |
TEVA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.9% | -11.5% | -33% | -22% |
| Consumer Discretionary | XLY | 0.2% | -10% | -20.7% | -14% |
| Consumer Staples | XLP | 0.7% | -8.4% | -29% | -6% |
| Energy | XLE | -3.6% | -14.7% | -24.8% | -0% |
| Financial | XLF | 0.8% | -10.7% | -31.1% | -26% |
| Health Care | XLV | 1.2% | -9.1% | -19.6% | 6% |
| Industrial | XLI | -0.6% | -11.1% | -35.4% | -23% |
| Materials | XLB | -1.3% | -11.7% | -32.1% | -4% |
| Real Estate | XLRE | 0.6% | -7.8% | -27.4% | -10% |
| Technology | XLK | -2.2% | -15.1% | -32.6% | -8% |
| Utilities | XLU | 0.9% | -9.3% | -30.9% | -20% |
| Aerospace & Defense | XAR | -1.2% | -11.8% | -46.7% | -46% |
| Biotech | XBI | -2% | -8.5% | -14.4% | 11% |
| Homebuilder | XHB | 0.8% | -14% | -20.6% | -2% |
| Retail | XRT | -0.6% | -9.5% | -23.8% | -8% |
TEVA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -4.2% | -14.8% | -22.2% | 6% |
| Natural Gas | UNG | 1.8% | 2.5% | -9.3% | 8% |
| Gold | GLD | 1% | -7.2% | -46.3% | -38% |
| Silver | SLV | -1.8% | -7.7% | -44.1% | -17% |
| Copper | CPER | -7% | -18% | -48.9% | -17% |
TEVA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 2.3% | -9% | -24.8% | 5% |
| iShares High Yield Corp. Bond | HYG | 0.2% | -9.3% | -26.9% | -8% |